FATE THERAPEUTICS INC — Director's Dealing 2018

May 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2018-05-02

Reporting Person: Coughlin Timothy P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-02	Stock Option (right to buy)	$9.78	A	16000	Acquired	2028-05-02	Common Stock (16000)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.

F2: Not applicable.